How Can Aesthetic Practitioners Lower The Risk Of Melasma Recurrence When Utilizing Ipl Devices? Practical Protocols And Expert Tips

Lowering melasma recurrence after IPL requires controlling melanocyte stimulation before, during, and after treatment. Aesthetic practitioners should use IPL conservatively, generally after at least six weeks of topical melanogenesis suppression, with appropriate filters, cooling, and a patch test. Immediately after each session, 15–20 minutes of combined red and infrared LED therapy may help calm inflammation, while strict photoprotection remains essential to reduce recurrence risk.

IPL can reduce visible pigment, but thermal irritation and ultraviolet exposure may reactivate melanocytes. The most reliable approach is a complete protocol: prepare the skin, use controlled IPL settings, reduce post-treatment inflammation, and maintain rigorous light protection.

Why Melasma Can Recur After IPL

IPL affects more than accumulated pigment

IPL produces broad-spectrum light, commonly across approximately 500–1200 nm. Although melanin is a target, light energy can also be absorbed by melanin in surrounding keratinocytes and melanocytes.

This non-specific absorption can create thermal irritation. In susceptible skin, that inflammation may trigger post-inflammatory hyperpigmentation (PIH) and stimulate renewed melanin production.

Melasma is biologically relapse-prone

Melasma involves both epidermal and dermal pigment dynamics, along with factors such as ultraviolet exposure and melanocyte hyperactivity. Removing existing pigment does not permanently eliminate the processes that created it.

IPL should therefore be viewed as a second-line or adjunctive treatment, rather than a standalone solution for a condition with a high tendency to relapse.

Prepare the Skin Before IPL

Use topical suppression first

Topical depigmenting treatment should generally precede IPL by at least six weeks. Depending on the patient and prescribing clinician, this may include hydroquinone, tretinoin, or a triple-combination formulation.

The purpose is to reduce melanocyte activity before exposing the skin to light and heat. This pre-conditioning can improve treatment tolerance and reduce the likelihood that IPL-induced inflammation will produce new pigment.

Assess risk factors individually

Patients with Fitzpatrick skin types III–VI have a greater risk of PIH after IPL and other energy-based procedures. Practitioners should also consider a history of PIH, recent tanning, active irritation, photosensitizing medications, and previous melasma flares after procedures.

A treatment plan should be individualized by a qualified medical professional, particularly when prescription depigmenting agents or anti-inflammatory medication may be appropriate.

Perform a localized patch test

A patch test helps reveal how the patient's skin responds to the selected filter, fluence, pulse structure, and cooling approach. Larger treatment areas should be postponed if the test site develops excessive erythema, blistering, prolonged inflammation, or worsening pigmentation.

Select and Operate IPL Conservatively

Choose appropriate cutoff filters

Filters in the approximate 570–615 nm range can be used to target resistant epidermal melasma while limiting unnecessary spectral exposure. The correct filter depends on the patient's skin type, pigment characteristics, and the device's output.

Filter selection should reduce excess absorption by surrounding epidermal melanin rather than simply maximize energy delivery.

Prefer uniform pulse delivery

Advanced IPL systems with a uniform pulse profile help avoid peak energy spikes and localized hot spots. Balanced delivery is important because uneven thermal exposure can increase irritation and PIH risk.

The device's output should be understood in the context of its actual pulse structure, not just its nominal fluence.

Favor conservative fluence and short, controlled protocols

High-fluence monotherapy can create thermal irritation and is associated with greater recurrence concerns. Lower-fluence, short-pulse protocols are generally more appropriate when treating melasma-prone skin.

The goal is controlled pigment improvement without excessive inflammation. Practitioners should avoid escalating energy simply to produce a more dramatic immediate endpoint.

Use active epidermal cooling

Integrated contact cooling, chilled gel, or other appropriate cooling methods can protect the epidermis and reduce pain, erythema, and overheating. Cooling is especially important when treating darker skin types or when higher fluences are clinically necessary.

Pulse splitting with suitable delay intervals can also allow heat to dissipate between pulses. Device-specific parameters must be followed because pulse duration and delay requirements vary by platform.

Calm Inflammation Immediately After IPL

Add combined red and infrared LED therapy

Clinical experience described in the primary reference supports administering 15–20 minutes of combined red and infrared LED therapy immediately after each IPL session.

This post-treatment step is intended to soothe treated tissue and reduce inflammation, which may lower the chance of melanocyte re-stimulation and subsequent pigment recurrence.

It should be considered an adjunct to careful IPL technique, not a substitute for pre-treatment suppression, cooling, or photoprotection.

Monitor the inflammatory response

Mild, expected erythema may occur, but marked swelling, blistering, significant pain, or prolonged inflammation should prompt clinical reassessment. Excessive inflammation increases concern for PIH.

When significant acute inflammation occurs, potent topical corticosteroids may sometimes be considered under appropriate medical supervision. They should not be used routinely or without evaluating the patient's clinical circumstances.

Maintain Strict Photoprotection

Treat photoprotection as part of the procedure

Strict sun protection is essential before and after IPL. Ultraviolet exposure can reactivate melanocytes and undermine the benefit of treatment, even when the IPL session itself was technically well controlled.

Patients should consistently use broad-spectrum sunscreen, reduce direct sun exposure, and use physical protection such as hats when appropriate.

Address visible-light exposure when relevant

Because melasma can be influenced by more than ultraviolet radiation, practitioners should discuss the patient's broader light exposure and daily habits. Consistent protection is more important than occasional high-SPF use after prolonged exposure.

The exact photoprotection plan should reflect the patient's lifestyle, skin type, and recurrence history.

Combine IPL With Maintenance Treatment

Continue topical therapy after improvement

Topical melanogenesis-suppressing agents may help maintain the reduction achieved with IPL. Without ongoing management, the underlying tendency toward melanocyte hyperactivity remains.

Maintenance treatment should be prescribed and monitored according to the patient's tolerance and clinical needs.

Use IPL for resistant disease

Topicals and, where appropriate, mild chemical peels generally remain first-line options. IPL is better reserved for refractory or predominantly epidermal cases that have not responded adequately to conservative treatment.

This sequencing reduces unnecessary exposure to a modality that can itself worsen pigment when used aggressively.

Understanding the Trade-offs

More energy does not guarantee a more durable result

Increasing fluence may produce faster visible pigment disruption, but it also increases epidermal heating and inflammation. The potential short-term gain can be offset by PIH or rapid recurrence.

A less aggressive series of treatments may provide a better risk-benefit balance than a single high-energy session.

IPL is not equally suitable for every patient

Broad-spectrum light has non-specific absorption in epidermal melanin. Patients with darker skin, active tanning, a history of PIH, or unstable melasma may require extra caution or a different treatment strategy.

In some cases, postponing IPL or using topical treatment alone is the more appropriate clinical decision.

Avoid unsupported expectations about recurrence prevention

Red and infrared LED therapy may help reduce post-treatment inflammation, but it does not permanently prevent melasma. Evidence and outcomes can vary by device, protocol, patient biology, and adherence to maintenance care.

Practitioners should present LED as a supportive measure within a broader protocol rather than as a guaranteed protective intervention.

Making the Right Choice for Your Goal

The safest IPL plan is determined by the patient's recurrence risk and the condition of the skin before treatment.

If your primary focus is minimizing PIH: Complete topical pre-treatment, perform a patch test, use conservative fluence, and apply effective epidermal cooling.
If your primary focus is reducing recurrence: Combine appropriate IPL with continued melanogenesis-suppressing therapy, immediate 15–20-minute red/infrared LED therapy, and strict photoprotection.
If your primary focus is treating darker skin types: Reduce energy as appropriate, prioritize cooling and uniform pulse delivery, and assess carefully for a history of PIH before proceeding.
If your primary focus is improving resistant melasma: Use IPL as an adjunct after conservative therapy has been attempted, rather than relying on high-fluence IPL monotherapy.

Durable melasma management depends less on aggressive pigment removal than on suppressing melanocyte activity and preventing inflammation and light exposure from restarting the process.

Summary Table:

Strategy	Key Actions
Pre-treatment	Topical suppression for 6+ weeks, patch test, assess skin type
During treatment	Use appropriate filters, uniform pulses, conservative fluence, cooling
Post-treatment	15-20 min LED therapy, monitor inflammation
Maintenance	Strict photoprotection, continue topical agents

At BELIS, we understand the complexities of treating melasma. Our advanced IPL systems are designed with uniform pulse profiles and effective cooling to help you achieve safe, effective results. Pair our technology with our expertise to enhance your practice. Contact us today to learn how our devices can support your melasma protocols. Contact us to schedule a demo or speak with our specialists.